Comar Evolves Brand to Assert Strength in Medical & Packaging Markets

Comar, a market-leading designer and manufacturer of innovative plastic solutions for the medical and healthcare markets, today unveiled a brand refresh including a new logo, visual elements, and market-specific sub-brands. The refresh comes as the company continues its growth trajectory and furthers its commitment to customer centricity.

“Since Comar’s founding 72 years ago, we’ve constantly been evolving to better serve our customers – through new services, capabilities, and engineered solutions, said Mike Ruggieri, CEO of Comar. “Furthering this spirit of evolution, I am excited to launch our brand refresh as a signal of our continual improvement and to herald the next evolution of Comar.”

Underlying this strategic and creative brand transformation is the organization’s deeply felt purpose of helping create solutions that enhance and extend lives. “For decades, Comar has maintained a consistent focus on solving ever more complex problems in the medical and healthcare markets. We respond to manufacturing challenges and regulatory hurdles with creative approaches and robust processes; we have earned a reputation as a partner you can rely on to launch high-impact packaging and medical solutions that positively impact the world around us,” said Ruggieri.

In addition to the visual brand refresh, the introduction of the company’s sub-brands provides the dedicated focus to conquer market-specific challenges for its customers. “United under the Comar brand, the newly unveiled Comar Medical and Comar Packaging Solutions sub-brands reflect our broad range of capabilities and our deep expertise to meet the distinct demands of each market,” said Scott Conklin, Executive Vice President of Sales and Marketing.

“We have experienced first-hand the unique rhythms and nuances across these verticals and we’re doubling down on our commitment to meeting our customers’ needs,” said Ruggieri. “This brand refresh is a reflection of our continued focus on delivering at the highest level for all of our customers, whatever that means for their specific project.”

Led by Comar’s internal marketing team, the company partnered with Philadelphia-based brand consultancy Finch Brands to develop the vision and creative direction for the refresh. The new brand approach will be rolled out across all materials in the coming weeks and further details can be found at the newly designed www.comar.com.

SourceComar

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”